There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes in P. falciparum populations in Nigeria, but one previous study has recorded a novel dhps mutation at codon 431 among infections imported to the United Kingdom from Nigeria. To assess how widespread this mutation is among parasites in different parts of the country and consequently fill the gap in sulfadoxine-pyrimethamine (SP) resistance data in Nigeria, we retrospectively analysed 1000 filter paper blood spots collected in surveys of pregnant women and children with uncomplicated falciparum malaria between 2003 and 2015 from four sites in the south and north. Genomic DNA was extracted from filter paper blood spots and...
Background: Malaria in Yemen is mainly caused by Plasmodium falciparum and 25 % of the population is...
Sulfadoxine-pyrimethamine (SP), the current first line antimalarial drug in Tanzania, is compromised...
Tanzania Health Research BulletinSulfadoxine-pyrimethamine (SP), the current first line antimalarial...
AbstractThere are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydr...
There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate ...
AbstractResistance to sulfadoxine–pyrimethamine (SP) in Plasmodium falciparum malaria parasites is a...
Item does not contain fulltextBoth use of sulphadoxine-pyrimethamine (SP) and SP-resistance of Plasm...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Resistance of Plasmodium falciparum to pyrimethamine is associated with a non-silent point mutation ...
Background. The success of Intermittent Preventive Treatment in Pregnancy (IPTp), Intermittent Preve...
Abstract. Resistance of Plasmodium falciparum to pyrimethamine is associated with a non-silent point...
BackgroundMutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes ...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
We assessed the prevalence of Plasmodium falciparum and the frequency of the dhfr triple mutation th...
Abstract. Point mutations in the genes for dihydrofolate reductase (DHFR) and dihydropteroate syntha...
Background: Malaria in Yemen is mainly caused by Plasmodium falciparum and 25 % of the population is...
Sulfadoxine-pyrimethamine (SP), the current first line antimalarial drug in Tanzania, is compromised...
Tanzania Health Research BulletinSulfadoxine-pyrimethamine (SP), the current first line antimalarial...
AbstractThere are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydr...
There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate ...
AbstractResistance to sulfadoxine–pyrimethamine (SP) in Plasmodium falciparum malaria parasites is a...
Item does not contain fulltextBoth use of sulphadoxine-pyrimethamine (SP) and SP-resistance of Plasm...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Resistance of Plasmodium falciparum to pyrimethamine is associated with a non-silent point mutation ...
Background. The success of Intermittent Preventive Treatment in Pregnancy (IPTp), Intermittent Preve...
Abstract. Resistance of Plasmodium falciparum to pyrimethamine is associated with a non-silent point...
BackgroundMutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes ...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
We assessed the prevalence of Plasmodium falciparum and the frequency of the dhfr triple mutation th...
Abstract. Point mutations in the genes for dihydrofolate reductase (DHFR) and dihydropteroate syntha...
Background: Malaria in Yemen is mainly caused by Plasmodium falciparum and 25 % of the population is...
Sulfadoxine-pyrimethamine (SP), the current first line antimalarial drug in Tanzania, is compromised...
Tanzania Health Research BulletinSulfadoxine-pyrimethamine (SP), the current first line antimalarial...